简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
HOME
·
TYK MEDICINES-B
TYK MEDICINES-B (02410.HK): Dovatinib mesylate tablets (TY-9591) granted conditional approval as first-line treatment for EGFR-mutant NSCLC with CNS metastases
Tags：
TYK MEDICINES-B
02410.HK
Clinical Progress
2026-08-27
TYK MEDICINES-B(02410.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 24.9 million, loss narrowed by 77.81% YoY
Tags：
TYK MEDICINES-B
02410.HK
loss narrowed
2026-08-18
TYK MEDICINES-B (02410.HK): Initiates Litigation over Disputed TY-9591 Cooperation Agreement and Takes Legal Proceedings against Sichuan Huayu
Tags：
TYK MEDICINES-B
02410.HK
Litigation
2026-07-23
Featured News
Research
HK Connect Weekly: HSTECH falls 0.77% for the week as Hang Seng Index quarterly review takes effect and Baidu completes dual primary listing - 20260904
Research
HK Newly Listed Stocks Weekly Tracker: AUX ELECTRIC's 1.3 Billion-Share Lock-up Expiry Lands Softly; UNISOUND Leads Rebound in Newer Listings - 20260904
Research
Going Global Weekly Report: Pharma Firms Sealed Licensing Deals at a Fast Pace as Semiconductors and E-Commerce Accelerate toward HK Listings - 20260904
Research
HK Stock Connect Daily Report: PHANCY Surged Nearly 15%; Hang Seng Index Quarterly Review Effective Today, Goldman Sachs Expects USD 870 Million of Passive Inflows into Tech Hardware - 20260904
Research
Weekly Hong Kong ETFs Average Return Statistics (by Fund Manager) (Third Week of August 2026)
Research
Weekly Hong Kong ETFs Return Statistics (First Week of September 2026)
Finance
CBHB (09668.HK): Completes Issuance of RMB 15 Billion Financial Bonds
Finance
RAINMED-B (02297.HK): Wang Lin Resigns as Non-Executive Director; Lu Xun Appointed
Research
Weekly Shanghai-Shenzhen Stock Connect ETF Average Return Statistics (by Fund Manager) (First Week of September 2026)
Finance
KANGDA ENV (06136.HK): Completes Issuance of USD 50 Million 8.0% Senior Notes Due 2029
Scan QR Code
Download App
